In a strategic move blending technological innovation with environmental consciousness, SGD Pharma has invested over €20 million to advance its facility in Zhanjiang, China. This significant refurbishment is not merely about upgrading the equipment but is part of a greener manifesto—committing to substantial CO2 reduction goals. Aligning with the Science Based Targets initiative (SBTi), SGD Pharma sets its sight on a 35% reduction in carbon emissions by 2030 and a whopping 65% by 2040. This ambition places the pharmaceutical glassware manufacturer on a 1.5°C decarbonization trajectory, revealing the depth of their pledge to sustainability and industrial progress.The comprehensive rebuild of the plant’s furnace is at the heart of this initiative, combining state-of-the-art design with cutting-edge technology. This not only boosts production capacity but also markedly improves energy efficiency, providing SGD Pharma with a dual advantage. By significantly lowering the facility’s carbon footprint, SGD Pharma stands as an exemplar in the industry, marrying high-quality production with ecological stewardship.
